Vibration-Induced-Emission (VIE) for imaging amyloid β fibrils

被引:26
作者
Dou, Wei-Tao
Chen, Wei
He, Xiao-Peng [1 ]
Su, Jianhua
Tian, He [1 ]
机构
[1] East China Univ Sci & Technol, Sch Chem & Mol Engn, Key Lab Adv Mat, 130 Meilong Rd, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
IN-VIVO DETECTION; ALZHEIMERS-DISEASE; CASCADE HYPOTHESIS; PROTEIN; FLUORESCENCE; PLAQUES; PROBE; DERIVATIVES;
D O I
10.1039/c6fd00156d
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This paper discusses the use of N, N'-disubstituted-dihydrodibenzo[a, c]phenazines with typical Vibration-Induced-Emission (VIE) properties for imaging amyloid beta (A beta) fibrils, which are a signature of neurological disorders such as Alzheimer's disease. A water-soluble VIEgen with a red fluorescence emission shows a pronounced, blue-shifted emission with A beta peptide monomers and fibrils. The enhancement in blue fluorescence can be ascribed to the restriction of the molecular vibration by selectively binding to A beta. We determine an increasing blue-to-red emission ratio of the VIEgen with both the concentration and fibrogenesis time of A beta, thereby enabling a ratiometric detection of A beta in its different morphological forms. Importantly, the VIEgen was proven to be suitable for the fluorescence imaging of small Ab plaques in the hippocampus of a transgenic mouse brain (five months old), with the blue and red emissions well overlapped on the Ab. This research offers a new rationale to design molecular VIE probes for biological applications.
引用
收藏
页码:395 / 402
页数:8
相关论文
共 34 条
[1]   In Vivo Detection of Cerebral Amyloid Fibrils with Smart Dicynomethylene-4H-Pyran-Based Fluorescence Probe [J].
Cheng, Yan ;
Zhu, Biyue ;
Deng, Yue ;
Zhang, Zhirong .
ANALYTICAL CHEMISTRY, 2015, 87 (09) :4781-4787
[2]   Strategies for disease modification in Alzheimer's disease [J].
Citron, M .
NATURE REVIEWS NEUROSCIENCE, 2004, 5 (09) :677-685
[3]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909
[4]   The secretases: enzymes with therapeutic potential in Alzheimer disease [J].
De Strooper, Bart ;
Vassar, Robert ;
Golde, Todd .
NATURE REVIEWS NEUROLOGY, 2010, 6 (02) :99-107
[5]   Protein folding and misfolding [J].
Dobson, CM .
NATURE, 2003, 426 (6968) :884-890
[6]   Amyloid β-Protein Assembly and Alzheimer's Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation [J].
Economou, Nicholas J. ;
Giammona, Maxwell J. ;
Do, Thanh D. ;
Zheng, Xueyun ;
Teplow, David B. ;
Buratto, Steven K. ;
Bowers, Michael T. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (06) :1772-1775
[7]   Targeting protein aggregation for the treatment of degenerative diseases [J].
Eisele, Yvonne S. ;
Monteiro, Cecilia ;
Fearns, Colleen ;
Encalada, Sandra E. ;
Wiseman, R. Luke ;
Powers, Evan T. ;
Kelly, Jeffery W. .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (11) :759-780
[8]   Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease [J].
Fu, Hualong ;
Cui, Mengchao ;
Zhao, Liu ;
Tu, Peiyu ;
Zhou, Kaixiang ;
Dai, Jiapei ;
Liu, Boli .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) :6972-6983
[9]   ALZHEIMERS-DISEASE - THE AMYLOID CASCADE HYPOTHESIS [J].
HARDY, JA ;
HIGGINS, GA .
SCIENCE, 1992, 256 (5054) :184-185
[10]   Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease [J].
He, Gen ;
Luo, Wenjie ;
Li, Peng ;
Remmers, Christine ;
Netzer, William J. ;
Hendrick, Joseph ;
Bettayeb, Karima ;
Flajolet, Marc ;
Gorelick, Fred ;
Wennogle, Lawrence P. ;
Greengard, Paul .
NATURE, 2010, 467 (7311) :95-U129